TATA Health International (HKG:1255) reported HK$20.6 million in attributable profit for the first half of 2025, swinging from a loss of HK$5.1 million a year earlier, according to a Hong Kong bourse filing Sunday.
Earnings per share was HK$0.08, compared with a loss of HK$0.02 in the prior year.
The footwear company's revenue fell 42% year-on-year to HK$42.1 million, figures showed.
Shares of the company remain suspended from trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.